Microfluidics: Big developments on thesmall scale

February 23, 2023

Life sciences is a blanket term used to describe the study of all things relative to living organisms, such as biology, physiology, and biochemistry.

Spotlight

Biotech Mills

BioTech Mills, Inc. is a private Delaware corporation headquartered in Snow Hill, North Carolina, which develops and manufactures renewable natural plant and plant fiber products. The company owns and operates the largest natural bast fiber processing and manufacturing facility in North America. Our factory locations are in Snow Hill, North Carolina, Eastman, Georgia and Calcutta, India. The company also has manufacturing facilities that provide the largest amount of natural oil absorbents in North America with inventories of over 35,000,000 pounds. Our oil spill absorbent products and containment hard booms are shipped globally to contain and absorb even the largest oil spills. Our containment oil spill products meet the latest oil industry specifications for hard booms.

OTHER WHITEPAPERS

Cell and Gene Therapy Hot Buttons Series

whitePaper | September 27, 2022

Cell and Gene Therapy (CAGT) activity has increased dramatically in recent decades, especially in Chimeric Antigen Receptor T-Cell (CAR-T) clinical trials and therapy registrations. The IQVIA CAGT Hot Buttons series covers basic concepts in CAGT for newcomers to this field.

THE RNA PLATFORM

whitePaper | May 26, 2022

Exploring biomarkers with the new central dogma. It can be a daunting decision for scientists to know when to focus on DNA, messenger RNA (mRNA), non-coding RNA (ncRNA) or protein biomarkers for routine clinical use, with each exhibiting its own strengths and limitations

Accelerating the Biomanufacturing Revolution

whitePaper | February 11, 2022

The biomanufacturing revolution is here. Recent advancements in the field of synthetic biology have enabled significant cost reductions in foundational bioengineering unit operations such as DNA synthesis and sequencing.

Advanced Biopharmaceutical Manufacturing: An Evolution Underway

whitePaper | June 5, 2022

The past decade has seen a significant shift in the nature of the products being manufactured and sold by the innovative biopharmaceutical (biopharma) industry. The global biopharmaceutical portfolio of today reflects increased therapeutic competition, a greater prevalence of large molecule drugs, expansion in the number of personalized or targeted products, and a rise of treatments for many orphan diseases.